Scientists test new shot to fight deadly diarrhea virus
NCT ID NCT06485258
Summary
This study tested a new type of rotavirus vaccine given as a shot, not a liquid. The goal was to see if it was safe and if it triggered an immune response in healthy adults. Fifty participants received three injections over two months and were monitored for side effects and antibody levels. This early-phase research aims to develop a more effective vaccine to protect infants, especially in areas where current oral vaccines don't work as well.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ROTAVIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory Children's Center - Vaccine Research Clinic
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.